Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 53, pseudogene (RNU6-53P) is a genomic pseudogene that arises from retrotransposition events involving U6 small nuclear RNA, a highly conserved uridine-rich non-coding RNA critical for mRNA splicing via the spliceosome. The U6 snRNA gene is frequently mobilized by template switching and retrotransposition mechanisms, especially involving LINE-1 elements, generating chimeric snRNA pseudogenes that are widely dispersed throughout the genome. These pseudogenes, including RNU6-53P, do not produce functional RNA or protein products and are not known to participate in specific biological processes, therapeutic mechanisms, or diseases; however, they may serve as genomic markers of retrotransposon activity and genome evolution. Key points: - This is a pseudogene rather than a functional molecular target. - It is not a receptor, enzyme, transporter, or any functional protein. - It is not involved in cell signaling, disease, or any therapeutic pathways. - Its creation reflects the unique biology of U6 snRNA and retrotransposon dynamics, especially template switching with LINE-1 elements. If your context requires a true molecular/therapeutic target, this entity is not appropriate. If you seek genomic annotation or markers of retrotransposition, it is relevant.
None. Drugs do not target pseudogenes of U6 snRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 53, pseudogene (RNU6-53P).